Correction to: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway (Advances in Rheumatology, (2023), 63, 1, (45), 10.1186/s42358-023-00325-z)

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original version of this article [1], the affiliations were published incorrectly. The correct affiliations are given below: 1 Department of Geriatrics, Chongqing Medical University, Chongqing, 400010, China 2 Department of Geriatrics, Chongqing General Hospital, Chongqing, 400010, China The affiliations have been updated above and the original article has been corrected. The publisher would like to apologize for any inconvenience caused.

Cite

CITATION STYLE

APA

Liu, H., Yang, Y., Zhang, J., & Li, X. (2023, December 1). Correction to: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway (Advances in Rheumatology, (2023), 63, 1, (45), 10.1186/s42358-023-00325-z). Advances in Rheumatology. BioMed Central Ltd. https://doi.org/10.1186/s42358-023-00326-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free